Bio Pharma Dive
MAY 28, 2021
For decades, scientists have tried unsuccessfully to target the KRAS gene, which is often mutated in lung, colon and pancreatic cancers. Lumakras is the first drug proven effective.
Pharma Mirror
MAY 28, 2021
If you are trying to set up your own laboratory, then you should prepare for a myriad of expenses. Budgeting is a process that is required throughout the running of your lab. It keeps everything in order and ensures the continued efficiency of whatever operation or experiment you are overseeing. Without the proper financial backing, things may quickly fall apart soon after.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
MAY 28, 2021
The biotech and its partner CStone disclosed Phase 3 results in lung cancer that support approval plans for a drug similar to treatments like Merck's Keytruda, but would be priced at a fraction of the cost.
Scienmag
MAY 28, 2021
Features of large systems yielded from tiny simulations with super-resolution techniques Credit: Tokyo Metropolitan University Tokyo, Japan – Researchers from Tokyo Metropolitan University have enhanced “super-resolution” machine learning techniques to study phase transitions. They identified key features of how large arrays of interacting “particles” behave at different temperatures by simulating tiny arrays before using a […].
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Bio Pharma Dive
MAY 28, 2021
The public offering follows just three months after Centessa, created from the merger of 10 Medicxi-backed drug startups, launched with $250 million in venture funding.
Pharma Times
MAY 28, 2021
Tremfya has already been recommended for NHS use to treat eligible patient with moderate-to-severe plaque psoriasis
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Scienmag
MAY 28, 2021
Credit: Tatjana Hirschmugl A new study exploits the characteristic epigenetic signatures of childhood tumors to detect, classify and monitor the disease. The scientists analyzed short fragments of tumor DNA that are circulating in the blood. These “liquid biopsy” analyses exploit the unique epigenetic landscape of bone tumors and do not depend on any genetic alterations, […].
Pharma Times
MAY 28, 2021
In Phase III, adjuvant treatment with Tagrisso reduced the risk of disease recurrence or death by 80% in the overall population
Scienmag
MAY 28, 2021
Baylor researchers, led by Bryan Shaw, found oral tactile visualization of complex 3D structures to be as accurate as eyesight Credit: Robert Rogers, Baylor Marketing & Communications WACO, Texas (May 28, 2021) – About 36 million people have blindness including 1 million children. Additionally, 216 million people experience moderate to severe visual impairment.
Drug Patent Watch
MAY 28, 2021
Annual Drug Patent Expirations for DOCETAXEL Docetaxel is a drug marketed by Accord Hlthcare, Actavis Llc, Amneal, Apotex Inc, Dfb Oncology Ltd, Dr Reddys Labs Ltd, Hikma, Hong Kong, Hospira…. The post New patent for Shilpa drug DOCETAXEL appeared first on DrugPatentWatch - Make Better Decisions.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Scienmag
MAY 28, 2021
Credit: Melissa Logies DALLAS – May 28, 2021 – A study of gene activity in the brain’s hippocampus, led by UT Southwestern researchers, has identified marked differences between the region’s anterior and posterior portions. The findings, published today in Neuron, could shed light on a variety of brain disorders that involve the hippocampus and may […].
NY Times
MAY 28, 2021
The United States began vaccinating children in that age group earlier this month.
Scienmag
MAY 28, 2021
A UTA first: Subbarao named American Astronautical Society fellow Credit: UT Arlington Kamesh Subbarao, a professor in the Mechanical and Aerospace Engineering (MAE) Department at The University of Texas at Arlington, is the University’s first faculty member to earn the honor of fellow of the American Astronautical Society (AAS). Subbarao, who has been at UTA […].
Drug Patent Watch
MAY 28, 2021
Annual Drug Patent Expirations for XADAGO Xadago is a drug marketed by Mdd Us and is included in one NDA. It is available from one supplier. There are three patents…. The post New patent for Mdd Us drug XADAGO appeared first on DrugPatentWatch - Make Better Decisions.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Scienmag
MAY 28, 2021
Credit: Courtesy Dwyer Lab University of Virginia School of Medicine researchers have shed new light on how our brains develop, revealing that the very last step in cell division is crucial for the brain to reach its proper size and function. The new findings identify a potential contributor to microcephaly, a birth defect in which […].
XTalks
MAY 28, 2021
NuttZo, a mixed nut and seed butter company, has entered the tahini spread market by introducing its new NuttZo Five-Seed Tahini Fusion. . This tahini-style seed butter is made with sesame, flax, sunflower, pumpkin and chia seeds and delivers an authentic tahini-packed flavor filled with nutrients and protein. “During quarantine, I discovered Tahini and was so impressed by how versatile it is.
Scienmag
MAY 28, 2021
Scientists at IST Austria discover how the HIV-related Rous sarcoma virus is assembled driving virus research forward. Credit: Marti Obr, IST Austria Viruses are perfect molecular machines. Their only goal is to insert their genetic material into healthy cells and thus multiply. With deadly precision, they thereby can cause diseases that cost millions of lives […].
Pharma Times
MAY 28, 2021
Clinical diagnostics company said dispute may have a material impact on its Q1 revenues
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Scienmag
MAY 28, 2021
It is the first work to show that sonothermogenetics can control behavior by stimulating a specific target deep in the brain Credit: Chen Ultrasound Lab Neurological disorders such as Parkinson’s disease and epilepsy have had some treatment success with deep brain stimulation, but those require surgical device implantation. A multidisciplinary team at Washington University in […].
XTalks
MAY 28, 2021
Will a new climate-centered diet have the potential to change the food industry for the better? In this episode of the Xtalks Food Podcast, Sydney discusses the climatarian diet, a growing trend in which individuals consume foods that are least harmful for the environment. The team has a thoughtful discussion about the environmental impact of importing out-of-season produce and how food and beverage brands can reduce their carbon footprints. .
Scienmag
MAY 28, 2021
Risk of mosquito-borne pathogen spreading to the country will increase as temperatures rise, say scientists Credit: Fabrizio Montarsi, CC BY 3.0 Climate change will make outbreaks of West Nile virus more likely in the UK within the next 20-30 years, scientists say. West Nile virus is spread by mosquitoes and has no vaccine. Most people […].
pharmaphorum
MAY 28, 2021
In this latest podcast, pharmaphorum spoke to Andrew Meade, life sciences lead UK and Ireland at Accenture, about the trends that emerged in this year’s Q1 results season. Meade talked about the prospects for the industry as the UK and other economies beginning to recover from the devastating pandemic. He discussed how COVID vaccines have raised the profile of the pharma industry in the perception of the general public.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Scienmag
MAY 28, 2021
New drug combination found to be effective against high-risk leukaemia Australian scientists have found what could prove to be a new and effective way to treat a particularly aggressive blood cancer in children. Acute lymphoblastic leukaemia, or ALL, is the most common cancer diagnosed in children. Despite dramatic improvements in the survival of children with […].
pharmaphorum
MAY 28, 2021
Ashfield Engage has completed the acquisition of Nuvera, a US-based healthcare consulting firm specialising in patient support programmes. Ashfield Engage and Nuvera will offer integrated specialist support and services including late-phase clinical trial experience, implementation and post-commercialisation satisfaction benchmarking and service optimisation.
Scienmag
MAY 28, 2021
The drug diABZI — which activates the body’s innate immune response — was highly effective in preventing severe COVID-19 in mice that were infected with SARS-CoV-2, according to scientists in the Perelman School of Medicine at the University of Pennsylvania. The findings, published this month in Science Immunology, suggest that diABZI could also treat other […].
Clinical Trial Gurus
MAY 28, 2021
Every study sponsor will provide the site with minimum requirements for how to store study drug. In some cases, the sponsor may ask that extra precautions are taken at the site to ensure that the medication is highly restricted. This is typical for pain studies that use controlled substances and may require the site to have medicine cabinets securely bolted prior to drug shipment.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Scienmag
MAY 28, 2021
Researchers detect internal motor structure of Mycoplasma mobile using high-speed atomic force microscopy Credit: Yuya Sasajima (Osaka City University) Much of human invention and innovation has been the result of our discovery and replication of natural phenomena, from birds serving to inspire human flight, to whales allowing us to dive deep into the ocean with […].
Pharma Times
MAY 28, 2021
Latest NHS waiting list figures show that 4.
Scienmag
MAY 28, 2021
MUSC Hollings Cancer Center researcher awarded Young Investigator Award to study the function of protein CDK6 in T-cells for melanoma therapy Credit: MUSC/Marquel Coaxum MUSC Hollings Cancer Center researcher Haizhen (Jen) Wang, Ph.D., recently was awarded a three-year $225,000 Young Investigator grant from the Melanoma Research Alliance. MRA research awards support innovative ideas that offer […].
Pharma Times
MAY 28, 2021
UK’s Vaccine Taskforce has secured 20 million doses of the vaccine, with initial deliveries expected 'later this year'
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
361 
Let's personalize your content